SCHEMBL5520684

SCHEMBL5520684

C[Si](C)(C)C[C@H](N)C(=O)NC1(C#N)CC1

nearest known ligand 0.53

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CTSC P53634 2/20 0.53
CTSL P07711 13/20 0.41
CTSS P25774 8/20 0.39
CTSK P43235 7/20 0.39
CTSB P07858 6/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5512889 1.00 CTSC (0.53) CTSCCTSLCTSSCTSKCTSB
SCHEMBL5518095 0.90 CTSC (0.48) CTSCCTSLCTSSCTSKCTSB
SCHEMBL5516206 0.87 CTSC (0.43) CTSCCTSLCTSSCTSKCTSB
SCHEMBL18910071 0.82 CTSC (0.53) CTSCCTSLCTSSCTSKCTSB
SCHEMBL8218554 0.79 CTSL (0.54) CTSCCTSLCTSSCTSKCTSB
SCHEMBL4675931 0.79 CTSL (0.54) CTSCCTSLCTSSCTSKCTSB
SCHEMBL20467579 0.79 CTSC (0.53) CTSCCTSLCTSSCTSKCTSB
Hydrochloric Acid SCHEMBL23673461 0.78 CTSL (0.53) CTSCCTSLCTSSCTSKCTSB
SCHEMBL8296697 0.78 CTSC (0.50) CTSCCTSLCTSSCTSKCTSB
Hydrochloric Acid SCHEMBL23673462 0.78 CTSL (0.53) CTSCCTSLCTSSCTSKCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070088001-A1 Silinane compounds as cysteine protease inhibitors QUEST DIAGNOSTICS INVESTMENTS LLC 2007-04-19 US claimed
US-20070088001-A1 Silinane compounds as cysteine protease inhibitors QUEST DIAGNOSTICS INVESTMENTS LLC 2007-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070088001-A1 Silinane compounds as cysteine protease inhibitors CTSV, CTSB, CTSS CTSC 15/4885CTSL 9/4885CTSS 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.